| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/17/2023 | — | Raymond James | Downgrades | Outperform → Market Perform | |
| 06/08/2023 | 28.53% | TD Cowen | $8 → $10 | Maintains | Outperform |
| 05/08/2023 | -35.73% | Barclays | $4 → $5 | Maintains | Underweight |
| 05/05/2023 | 15.68% | Raymond James | $10 → $9 | Maintains | Outperform |
| 05/03/2023 | 15.68% | Roth MKM | → $9 | Initiates Coverage On | → Buy |
| 05/02/2023 | — | Barclays | Downgrades | Equal-Weight → Underweight | |
| 04/27/2023 | 41.39% | Telsey Advisory Group | → $11 | Reiterates | → Outperform |
| 03/21/2023 | 15.68% | Oppenheimer | $12 → $9 | Maintains | Outperform |
| 03/02/2023 | -19.67% | Goldman Sachs | $5.5 → $6.25 | Maintains | Sell |
| 03/01/2023 | 28.53% | Credit Suisse | $12 → $10 | Maintains | Outperform |
| 03/01/2023 | -19.67% | Goldman Sachs | $5.5 → $6.25 | Maintains | Sell |
| 03/01/2023 | 41.39% | Telsey Advisory Group | $12 → $11 | Maintains | Outperform |
| 02/22/2023 | 54.24% | Telsey Advisory Group | $9 → $12 | Maintains | Outperform |
| 02/01/2023 | 28.53% | Raymond James | $8 → $10 | Maintains | Outperform |
| 01/31/2023 | 41.39% | Cowen & Co. | $6 → $11 | Maintains | Market Perform |
| 11/17/2022 | 54.24% | Oppenheimer | $22 → $12 | Maintains | Outperform |
| 11/14/2022 | -29.31% | Goldman Sachs | $7.5 → $5.5 | Maintains | Sell |
| 11/14/2022 | -22.88% | Barclays | $9 → $6 | Maintains | Equal-Weight |
| 11/11/2022 | -10.03% | Morgan Stanley | $10 → $7 | Maintains | Equal-Weight |
| 11/11/2022 | 2.83% | Raymond James | $12 → $8 | Downgrades | Strong Buy → Outperform |
| 11/11/2022 | 15.68% | Telsey Advisory Group | $10 → $9 | Maintains | Outperform |
| 11/08/2022 | 54.24% | Raymond James | $15 → $12 | Maintains | Strong Buy |
| 11/04/2022 | 28.53% | Telsey Advisory Group | $17 → $10 | Maintains | Outperform |
| 10/25/2022 | 28.53% | Morgan Stanley | $11 → $10 | Maintains | Equal-Weight |
| 10/14/2022 | 15.68% | Barclays | $15 → $9 | Downgrades | Overweight → Equal-Weight |
| 08/08/2022 | 41.39% | Morgan Stanley | $12 → $11 | Maintains | Equal-Weight |
| 08/05/2022 | 92.8% | Barclays | $13 → $15 | Maintains | Overweight |
| 07/21/2022 | — | Keybanc | Initiates Coverage On | → Sector Weight | |
| 07/21/2022 | -10.03% | Goldman Sachs | $14 → $7 | Downgrades | Neutral → Sell |
| 06/30/2022 | 92.8% | Raymond James | → $15 | Initiates Coverage On | → Strong Buy |
| 05/16/2022 | 67.1% | Barclays | $34 → $13 | Maintains | Overweight |
| 05/16/2022 | 182.78% | Oppenheimer | $45 → $22 | Maintains | Outperform |
| 05/16/2022 | 54.24% | B of A Securities | $32 → $12 | Downgrades | Buy → Neutral |
| 05/13/2022 | 54.24% | Morgan Stanley | $25 → $12 | Maintains | Equal-Weight |
| 05/13/2022 | 92.8% | Credit Suisse | $26 → $15 | Maintains | Outperform |
| 05/13/2022 | 169.92% | Telsey Advisory Group | $30 → $21 | Maintains | Outperform |
| 04/07/2022 | 311.31% | Truist Securities | → $32 | Initiates Coverage On | → Buy |
| 03/10/2022 | 337.02% | Barclays | $38 → $34 | Maintains | Overweight |
| 03/09/2022 | 311.31% | B of A Securities | $40 → $32 | Maintains | Buy |
| 03/09/2022 | 362.72% | Piper Sandler | $45 → $36 | Maintains | Overweight |
| 03/09/2022 | 234.19% | Credit Suisse | $34 → $26 | Maintains | Outperform |
| 03/03/2022 | 285.6% | Telsey Advisory Group | $46 → $30 | Maintains | Outperform |
| 03/01/2022 | 285.6% | Goldman Sachs | $35 → $30 | Maintains | Neutral |
| 02/07/2022 | — | Cowen & Co. | Downgrades | Outperform → Market Perform | |
| 01/20/2022 | 337.02% | Keybanc | $45 → $34 | Maintains | Overweight |
| 01/11/2022 | 337.02% | Credit Suisse | $42 → $34 | Maintains | Outperform |
| 11/11/2021 | 439.85% | Credit Suisse | $41 → $42 | Maintains | Outperform |
| 08/13/2021 | 362.72% | Morgan Stanley | $34 → $36 | Maintains | Equal-Weight |
| 08/13/2021 | 491.26% | Telsey Advisory Group | $43 → $46 | Maintains | Outperform |
| 06/21/2021 | 452.7% | Cowen & Co. | → $43 | Initiates Coverage On | → Outperform |
| 06/21/2021 | 439.85% | B of A Securities | → $42 | Initiates Coverage On | → Buy |
| 06/21/2021 | 259.9% | Goldman Sachs | → $28 | Initiates Coverage On | → Neutral |
| 06/21/2021 | 478.41% | Oppenheimer | → $45 | Initiates Coverage On | → Outperform |
| 06/21/2021 | 337.02% | Morgan Stanley | → $34 | Initiates Coverage On | → Equal-Weight |
| 06/21/2021 | 452.7% | Telsey Advisory Group | → $43 | Initiates Coverage On | → Outperform |
| 06/21/2021 | 542.67% | Barclays | → $50 | Initiates Coverage On | → Overweight |
| 06/21/2021 | 349.87% | Piper Sandler | → $35 | Initiates Coverage On | → Overweight |
| 06/21/2021 | 478.41% | Keybanc | → $45 | Initiates Coverage On | → Overweight |
What is the target price for FIGS (FIGS)?
The latest price target for FIGS (NYSE: FIGS) was reported by Raymond James on July 17, 2023. The analyst firm set a price target for $0.00 expecting FIGS to fall to within 12 months (a possible -100.00% downside). 29 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for FIGS (FIGS)?
The latest analyst rating for FIGS (NYSE: FIGS) was provided by Raymond James, and FIGS downgraded their market perform rating.
When is the next analyst rating going to be posted or updated for FIGS (FIGS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of FIGS, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for FIGS was filed on July 17, 2023 so you should expect the next rating to be made available sometime around July 17, 2024.
Is the Analyst Rating FIGS (FIGS) correct?
While ratings are subjective and will change, the latest FIGS (FIGS) rating was a downgraded with a price target of $0.00 to $0.00. The current price FIGS (FIGS) is trading at is $7.78, which is out of the analyst's predicted range.